Seagen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Seagen and buy or sell other stocks, ETFs, and their options commission-free!About SGEN
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers.
CEODavid R. Epstein, MBA
CEODavid R. Epstein, MBA
Employees—
Employees—
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded1997
Founded1997
Employees—
Employees—
SGEN Key Statistics
Market cap39.20B
Market cap39.20B
Price-Earnings ratio-57.10
Price-Earnings ratio-57.10
Dividend yield—
Dividend yield—
Average volume3.45M
Average volume3.45M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$228.96
52 Week high$228.96
52 Week low$123.77
52 Week low$123.77
Stock Snapshot
Seagen(SGEN) stock is priced at $228.74, giving the company a market capitalization of 39.2B. It carries a P/E multiple of -57.10.
Seagen(SGEN) stock opened on 2025-11-09 at —. The price climbed to — and dipped to —.
The Seagen(SGEN)'s current trading volume is 0, compared to an average daily volume of 3.45M.
In the last year, Seagen(SGEN) shares hit a 52-week high of $228.96 and a 52-week low of $123.77.
In the last year, Seagen(SGEN) shares hit a 52-week high of $228.96 and a 52-week low of $123.77.
People also own
Based on the portfolios of people who own SGEN. This list is generated using Robinhood data, and it’s not a recommendation.